Viewing nowNewStatin Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201401264 · Approved 2014.03.19 · Insurance code 647803940
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is used as an adjunct when dietary measures and exercise alone are insufficient to control lipid disorders such as primary hypercholesterolemia and mixed hyperlipidemia. It can also be used in combination with diet or other therapies for patients with homozygous familial hypercholesterolemia to effectively lower cholesterol levels. It helps delay the progression of atherosclerosis by managing total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia. It is also used as an adjunct to diet in children aged 10 to 17 years with heterozygous familial hypercholesterolemia, especially when they meet risk criteria. Additionally, it is used as an adjunct to diet in patients with type III dysbetalipoproteinemia. In adults at high risk for cardiovascular disease, it helps reduce the risks of stroke, myocardial infarction, and arterial revascularization. In summary, this medication is used to reduce the risk and treat various forms of hypercholesterolemia and related cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses above 20 milligrams in pediatric patients.) The dose should be individualized according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. Do not take if you have allergies to any components of this medication or have active liver disease. Patients with myopathy or those taking cyclosporine and individuals with severe renal impairment should not use this medication. Pregnant or nursing women, and women of childbearing age who are not using adequate contraception must consult a physician prior to taking this medication. Patients at high risk for muscle disease are prohibited from using high doses, and special caution is needed for those with these risk factors when using this medication. This medication contains lactose, therefore patients with lactose intolerance or related genetic disorders should avoid it. Patients who consume alcohol excessively or have a history of liver disease should have regular liver function tests before and during taking this medication. If symptoms such as muscle pain, weakness, or cramps occur, inform healthcare professionals immediately and get tested. If clinical muscle damage is suspected, this medication may be discontinued, and the decision to re-administer depends upon physician discretion after symptom improvement. This drug may interact with other medications, therefore it is essential to inform healthcare professionals of any other medications being taken. Particularly, caution should be taken as the risk of muscle-related side effects increases when used in conjunction with fibrates. During pregnancy, this medication can pose risks to the fetus, hence it should be avoided if planning to conceive or if pregnant. There is no specific antidote for overdose, and appropriate treatment along with liver function and muscle enzyme tests are necessary based on symptoms. Dizziness may occur when taking this medication; therefore, caution should be exercised when driving or operating machinery. Rarely, various side effects such as skin rash, headache, dyspepsia, liver dysfunction, etc., have been reported, and consultation with healthcare professionals should occur immediately if unusual symptoms arise. It can also be used in children and adolescents, but careful monitoring of its effects on growth and development is necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. Proper storage can help safely maintain the medication's effectiveness.
Pink, round film-coated tablets
Domestic use - 30 tablets/box [10 tablets/PTP*3], Domestic use - 100 tablets/bottle, Export use - 28 tablets/box [14 tablets/PTP*2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.